Hims & Hers Health Files 8-K/A Amendment

Ticker: HIMS · Form: 8-K/A · Filed: 2024-04-26T00:00:00.000Z

Sentiment: neutral

Topics: amendment, governance, executive-compensation

Related Tickers: HIMS

TL;DR

Hims & Hers amended its 8-K to update director and exec comp info.

AI Summary

Hims & Hers Health, Inc. filed an 8-K/A on April 26, 2024, to amend a previous filing regarding changes in directors and officers, and compensatory arrangements. The amendment specifically addresses the election of new directors and updates related to executive compensation, effective March 30, 2024.

Why It Matters

This filing provides updated information on the company's board of directors and executive compensation, which are key governance factors for investors.

Risk Assessment

Risk Level: low — This is an amendment to a previous filing, primarily providing updated governance and compensation details, which typically carries a low immediate risk.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K/A filing?

The primary purpose is to amend a previous 8-K filing to update information regarding the departure of directors, election of directors, appointment of officers, and compensatory arrangements of certain officers.

What is the effective date of the changes reported in this amendment?

The date as of which the changes are reported is March 30, 2024.

When was this 8-K/A filing submitted to the SEC?

This 8-K/A filing was submitted on April 26, 2024.

What was Hims & Hers Health, Inc. formerly known as?

Hims & Hers Health, Inc. was formerly known as Oaktree Acquisition Corp.

What specific items of Form 8-K are being amended?

The filing amends items related to the Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; and Compensatory Arrangements of Certain Officers.

From the Filing

0001773751-24-000112.txt : 20240426 0001773751-24-000112.hdr.sgml : 20240426 20240426090925 ACCESSION NUMBER: 0001773751-24-000112 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240330 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240426 DATE AS OF CHANGE: 20240426 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hims & Hers Health, Inc. CENTRAL INDEX KEY: 0001773751 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38986 FILM NUMBER: 24879127 BUSINESS ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 BUSINESS PHONE: 415-851-0195 MAIL ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 FORMER COMPANY: FORMER CONFORMED NAME: Oaktree Acquisition Corp. DATE OF NAME CHANGE: 20190412 8-K/A 1 hims-20240330.htm 8-K/A hims-20240330 0001773751 false 0001773751 2024-03-30 2024-03-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________________________________________________________________________________ FORM  8-K/A _____________________________________________________________________________________________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2024 _____________________________________________________________________________________________________________________ HIMS & HERS HEALTH, INC. (Exact name of registrant as specified in its charter) _____________________________________________________________________________________________________________________ Delaware   001-38986   98-1482650 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) 2269 Chestnut Street, #523 San Francisco , CA 94123 (Address of principal executive offices) ( 415 ) 851-0195 (Registrant’s telephone number, including area code) ______________________________________________________________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading symbol Name of each exchange on which registered Class A Common Stock, $0.0001 par value   HIMS   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).  Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐ Item 5.02 Departur

View on Read The Filing